Your browser is no longer supported. Please, upgrade your browser.
Settings
XPH SPDR S&P Pharmaceuticals ETF daily Stock Chart
XPH [NYSE]
SPDR S&P Pharmaceuticals ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-1.84%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month1.75%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-5.23%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-2.93%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-15.54%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range34.51 - 49.97 Perf YTD5.00%
Dividend0.29 P/FCF- EPS past 5Y- ROI- 52W High-23.05% Beta-
Dividend %0.75% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low11.42% ATR0.61
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)44.63 Volatility1.47% 1.42%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.44 Prev Close38.52
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume53.55K Price38.45
Recom- SMA20-1.23% SMA50-0.99% SMA200-6.17% Volume23,635 Change-0.18%
Jul-09-19 05:39PM  Why disclosing drug prices in TV ads won't lower costs Yahoo Finance
Jul-08-19 10:42AM  Health stocks under pressure in wake of Trump plan to issue executive order on drug pricing MarketWatch
Jul-05-19 04:22PM  Stocks end slightly lower after strong jobs report puts Fed rate cuts in question MarketWatch
01:43PM  Trump Today: President leans on Fed anew and mulls census executive order MarketWatch
Jun-26-19 11:00AM  AbbVie to Buy Allergan: Prescribed ETFs Zacks
Jun-25-19 06:01PM  AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs ETF Trends
07:42AM  Drug maker stocks rally after AbbVie's deal to buy Allergan for 45% premium MarketWatch
Jun-17-19 04:01PM  FDA approves non-insulin Type 2 diabetes drug for kids, the first to hit market in 20 years MarketWatch
Jun-10-19 07:51AM  Insys files for bankruptcy, stock plunges toward record low MarketWatch
May-14-19 05:40PM  Legal Troubles Beset Pharmaceutical Sector ETFs ETF Trends
May-13-19 02:59PM  Stocks of generic drug companies fall after more than 40 states file suit alleging price fixing MarketWatch
May-09-19 10:05AM  Pharma ETFs Down Despite Solid Q1 Results Zacks
May-02-19 02:28PM  Declining sales of blockbuster drug drag Teva revenue lower MarketWatch
Apr-23-19 03:11PM  3 Healthcare ETFs to Sell Amid Political Headwinds InvestorPlace
Apr-22-19 08:00AM  Can The Stock Market Keep Rising After A Strong First Quarter? Investor's Business Daily
Apr-19-19 08:02AM  Health-care drama has now spread to biopharma stocks MarketWatch
Apr-09-19 02:14PM  4 ETFs to Consider with Big Pharma on the Senates Hot Seat ETF Trends
Apr-03-19 12:23PM  Democrats, Republicans agree on legislation targeting drug prices MarketWatch
Mar-01-19 08:00AM  Why These Pharma ETFs Rallied on Thursday Zacks
Feb-28-19 04:43PM  Pharmaceutical ETFs Break Out on Horizon Pharmas Positive Drug Results ETF Trends
Feb-15-19 02:16PM  Medicare would cover CAR-T therapies under new CMS proposal MarketWatch
Feb-07-19 11:15AM  A Look at Pharma ETFs Post Q4 Results Zacks
Jan-29-19 07:29AM  Biogen stock up 3% after 4Q earnings beat MarketWatch
Jan-23-19 11:33AM  BMO downgrades Merck to market perform MarketWatch
Jan-06-19 09:32AM  Outlook For Battered Biotech Stocks In 2019 Investopedia
Dec-31-18 02:30PM  4 Top-Ranked Undervalued Sector ETFs to Buy in 2019 Zacks
Dec-21-18 12:55PM  Perrigo stock plunges toward biggest drop in 24 years after disclosing $1.9 billion Irish back-tax bill MarketWatch
Dec-17-18 12:25PM  7 Major Pharmaceutical Stocks to Quarantine Now InvestorPlace
Dec-14-18 09:55AM  5 Incredible ETFs & Stocks to Buy on the Dip Zacks
Nov-19-18 01:25PM  Yahoo Finance Live: The Final Round - Nov 19th, 2018 Yahoo Finance Video
Nov-12-18 03:46PM  5 Stocks to Sell After the Midterm Election InvestorPlace
Nov-08-18 01:00PM  Midterms Produce Split Congress: ETF Areas in Focus Zacks
Nov-07-18 04:28PM  Here are the stock-market sectors in the spotlight after midterm elections MarketWatch
Oct-29-18 08:50AM  Elections Could Affect These Health Care ETFs Investopedia
Oct-25-18 10:39AM  With Midterms Looming, Consider Healthcare ETFs ETF Trends
Oct-24-18 11:59AM  ETF Strategies for the Midterm Elections Zacks
Oct-22-18 03:30PM  ETF Plays for a Divided Midterm Elections ETF Trends
Oct-15-18 12:41PM  Johnson & Johnson Stock Can Still Pick Up Speed, Analyst Says Barrons.com
Oct-12-18 06:00AM  Top 5 Pharmaceutical ETFs for 2018 Investopedia
Sep-24-18 09:52AM  Resurgent Pfizer Stock Testing 19-Year Resistance Investopedia
Sep-06-18 04:56PM  Pharmaceutical ETFs Could Maintain Their Momentum ETF Trends
Aug-13-18 04:07PM  Health Care ETFs Outperforming: Will the Rally Last? Zacks
Aug-02-18 07:29AM  5 Best-Performing Sector ETFs of July InvestorPlace
Jul-20-18 06:00AM  AbbVie Is the Next Great Drug Short: Citron Investopedia
Jul-19-18 10:14AM  AbbVie shares drop 5.5% after short seller Citron calls it 'next great drug short' MarketWatch
Jul-09-18 07:13AM  KemPharm's stock soars after ADHD drug trial meets primary endpoints MarketWatch
Jul-03-18 03:19PM  July Could Be a Volatile Month for Pharma ETFs ETF Trends
Jun-08-18 01:19PM  Valeant Pharmaceuticals Intl Inc Has New Name But Same Problems InvestorPlace
Jun-04-18 11:01AM  Cramer: Pharmaceutical stocks are underperforming 'like nothing I've ever seen' CNBC
10:30AM  Cramer: Drug stocks are underperforming 'like nothing I'v... CNBC Videos
May-14-18 08:41AM  President Trumps big drug price speech boosts pharma stocks MarketWatch
Apr-02-18 12:12PM  Antibiotics Could Clean Up as M&A Catalyst Barrons.com
Mar-12-18 12:16PM  Pharmaceutical ETF Surges on Healthy Outlook ETF Trends
Feb-01-18 07:29AM  Pharmaceutical stocks drop after drug price mention in Trumps State of the Union MarketWatch
Jan-30-18 10:29AM  Health-care ETFs in focus on JP Morgan-Berkshire-Amazon d... CNBC Videos
Jan-25-18 11:10AM  Pfizer: Revenue Growth Is Expected in 4Q17 Market Realist
Jan-23-18 01:52PM  Mylan CEO: I'm excited about our pipeline Yahoo Finance Video
Jan-22-18 09:01AM  Merck & Co.s Animal Health Business in 3Q17 Market Realist
Jan-19-18 09:35AM  Johnson & Johnsons Revenue Estimates for 4Q17 Market Realist
Jan-18-18 10:47AM  Maybe High Drug Prices Are a Problem After All Barrons.com
Jan-17-18 04:35PM  Supernus Pharmaceuticals Stock Is an Institutional Favorite Investopedia
Jan-11-18 12:58PM  Is Valeant Pharmaceuticals Intl Inc a Buy? 3 Pros, 3 Cons InvestorPlace
10:32AM  Recent Developments for Mylan Market Realist
Jan-10-18 05:59PM  Corcept Therapeutics Stock Has Healthy Institutional Support Investopedia
Dec-28-17 10:31AM  Countdown to 2018: Merck Can Rise From the Muck Barrons.com
Nov-20-17 07:05AM  The FDA is cracking down on controversial supplement kratom MarketWatch
Nov-06-17 12:00PM  Pharmaceuticals Should Be Easy Pill to Swallow for 2018 Trump Trade TheStreet.com
Oct-26-17 02:11PM  EarningsWatch: Celgene tanks and Twitter spikes ahead of Amazon, Alphabet reports MarketWatch
Oct-24-17 06:06PM  Mercks 3Q17 Revenues Could Rise Market Realist
Oct-17-17 10:26AM  Neothetics's stock rockets on heavy volume after merger deal MarketWatch
Oct-16-17 12:33PM  President Trump reiterates that drug companies 'getting away with murder' but says not much else MarketWatch
Sep-20-17 11:47AM  Jump In Pet Adoptions Is Good News For Animal Health Stocks Barrons.com
Sep-19-17 05:09PM  ETF Flopper: Repeal and Replace Revived, Sinks Health-Care Stocks Barrons.com
Sep-11-17 07:36AM  Introducing Mercks 2Q17 Immuno-Oncology Blockbuster Market Realist
Sep-04-17 10:36AM  Eli Lillys Cardiovascular Products in 2Q17 Market Realist
Aug-30-17 10:37AM  Performance of Bristol-Myers Squibbs Eliquis in 2Q17 Market Realist
Aug-23-17 09:08AM  Defitelio Continues to Demonstrate Robust Demand Trends in 2017 Market Realist
Aug-21-17 02:36PM  Why Jazz Is Expected to Report a Robust Revenue Growth Rate Market Realist
Aug-11-17 08:42AM  Peregrine Pharmaceuticals laid off one-fifth of its workforce MarketWatch
Aug-07-17 12:10PM  Teva's stock keeps plunging on heavy volume after Morgan Stanley downgrade MarketWatch
09:45AM  Q2 Earnings Fail to Impress Pharma ETF Zacks
Aug-03-17 09:59AM  Three Large Cap Pharma Picks That Can Outperform This Year Barrons.com
07:55AM  Teva's stock plunges on heavy volume after profit miss and slashed outlook MarketWatch
Aug-01-17 07:41AM  Bristol-Myers Squibbs 2Q17 Earnings: Virology Products Market Realist
Jul-31-17 09:39AM  What Trump could do to make Obamacare implode MarketWatch
Jul-28-17 03:36PM  Eli Lillys Business Segments in 2Q17 Market Realist
Jul-26-17 04:35PM  Bristol-Myers Squibbs 2Q17 Estimates: Expect Growth! Market Realist
Jul-24-17 12:35PM  What Analysts Recommend for Eli Lilly ahead of 2Q17 Results Market Realist
Jul-14-17 09:09AM  Understanding Allergans Revenue Stream for 2017 Market Realist
Jul-11-17 10:47AM  This week could be make or break for the GOP health care bill MarketWatch
Jul-10-17 03:10PM  What Lies Ahead for Pharma ETFs in Second Half 2017 Zacks
07:21AM  Kala sets terms of IPO to raise up to $96 million MarketWatch
Jul-07-17 04:07PM  A Look at Pharmaceutical ETFs in 2Q17 Market Realist
Jul-06-17 07:45AM  Egalet's stock plunges toward record low after stock offering plan MarketWatch
Jul-04-17 09:06AM  Performance of Mercks Gardasil and Other Human Vaccines in 1Q17 Market Realist
Jun-29-17 08:28AM  Why did these generic drugs prices jump as much as 85%? MarketWatch
Jun-21-17 01:03PM  Drug stocks surge on report that President Trump plans to ease industry regulations MarketWatch
Jun-20-17 07:36AM  Key Updates on Eli Lillys Jardiance Market Realist
Jun-19-17 07:45AM  Valeant's stock surges after largest shareholder John Paulson elected to board MarketWatch
Jun-08-17 10:36AM  Why Pfizers Products Lost Market Share in 1Q17 Market Realist
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.